LDN & Multiple Sclerosis

Low Dose Naltrexone…

…And this is yet another treatment for MS… seems to be effective…but still needs to undergo a clinical trial to see if the original results can be replicated…

  • “Over the past few years, growing experience with the clinical use of LDN demonstrates its consistency in preventing further attacks in people with MS. In addition, a majority of such patients note reductions in spasticity and fatigue.
  • Clinically the results are strongly suggestive of efficacy. Ninety-eight to 99% of people experience no more disease progression, whether the disease category is relapsing-remitting or chronic progressive.
  • It should be emphasized that in spite of the plentitude of clinical experience described above, in the absence of a formal clinical trial of LDN in MS, these results cannot be considered scientific, but rather anecdotal. A clinical trial, preferably by a pharmaceutical company with some experience with MS, is clearly needed to determine whether these results can be replicated. If they can be, they are likely to lead to widespread use of this extremely non-toxic drug in the treatment of MS.”

For more information on the results from this research visit the respective LDN websites under links;)

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: